IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
AssigneeIowa State University Research Foundation, Inc.
InventorMICHAEL WAN CHO
Life of this patent
Estimating the term…
Abstract
Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.
Claims30
An immunogenic composition comprising the receptor-binding domain (RBD) of the Severe acute respiratory syndrome coronavirus (SARS-CoV-2) spike protein, and a carrier.
A nucleic acid sequence encoding a SARS-CoV-2 RBD of bases 333-528 operably linked to heterologous targeting, signaling, termination or promoter sequences.
Dependencies are inferred from the claim text.